Climate Change Data

PeptiDream Inc. and PDRadiopharma Inc. (PeptiDream Group)

Climate Impact & Sustainability Data (2020, 2021, 2023, FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma))

Reporting Period: 2020

Environmental Metrics

Total Carbon Emissions:1381 tCO2e/year
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:1381 tCO2e/year
Scope 3 Emissions:236 tCO2e/year
Total Energy Consumption:2946 MWh/year
Water Consumption:5312 m3/year
Waste Generated:102.4 tons/year

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Achieved S-Certification, the highest rank of the CASBEE environmental performance assessment for its new headquarters and laboratory.
  • Reduced CO2 emissions (Scope 1+2) to 1,381 tons in FY2020 (9.2 tons per employee).
  • Business-related waste recycling rate of approximately 100%.
  • Adopted an electricity supplier that proactively promotes renewable energy since August 2018.

Social Achievements

  • Female employee ratio of 38% (exceeds the pharmaceutical industry average).
  • 100% of female employees have taken childcare leave in the past eight years, with a 100% return and six-year retention rate.
  • Employee turnover rate of 3.2% (well below the industry average).
  • Actively participates in local community events and educational/academic activities.

Governance Achievements

  • Established an Auditing Committee with four independent external directors with voting rights.
  • Ratio of independent external directors is 57%.
  • Proactive and fair disclosure of corporate information.

Climate Goals & Targets

Short-term Goals:
  • Become "carbon neutral" in operations by 2026.

Environmental Challenges

  • Increasing water consumption during winter months due to humidifier use.
  • Managing Scope 3 emissions.
Mitigation Strategies
  • Considering more efficient methods for water usage during winter.
  • Implementing measures to reduce Scope 3 emissions (details not specified in report).

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: TCFD

Certifications: CASBEE S-Certification

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:7.72 tCO2e/year (2021); 0 tCO2e/year (2022)
Renewable Energy Share:100% (2022)

ESG Focus Areas

  • CO2 emission reduction and climate change
  • Reducing waste
  • Effective use of water resources and prevention of water pollution
  • Diversification of core human resources
  • Respect for diversity and creation of decent working environment
  • Respect for human rights and observance of occupational health and safety
  • Dialogue with shareholders, investors, and the broader community
  • Corporate governance
  • Compliance and risk management
  • Contribution to local communities

Environmental Achievements

  • Reduced 1.49 t CO2 (YoY) for CO2 emissions per employee (Scope1+2)
  • Switched to virtually CO2-free electricity across business operations in January 2022 (four years ahead of schedule)

Social Achievements

  • Appointed a female director in 2021
  • Established targets for 2030 for workforce diversity (at least 50% doctorate holders, 30% female managers, 30% foreign employees or employees with overseas work experience, 30% employees in their 20s/30s)
  • Supporting Japan's leading wheelchair rugby athletes
  • Implemented onboarding program to promote mutual understanding between organizations
  • Held monthly townhall meetings for all employees

Governance Achievements

  • Established the Sustainability and Governance Committee in 2021
  • Appointed an Independent External Director as Chairman of the Board of Directors
  • Amended Articles of Incorporation to allow the Chairman of the Board of Directors to be an independent external director
  • Conducted a scenario analysis on climate-related risks and opportunities in line with TCFD recommendations

Climate Goals & Targets

Long-term Goals:
  • Become a Drug Discovery Powerhouse in the next decade
Medium-term Goals:
  • Targets for 2030 for workforce diversity (at least 50% doctorate holders, 30% female managers, 30% foreign employees or employees with overseas work experience, 30% employees in their 20s/30s)
Short-term Goals:
  • Achieve carbon neutral across business operations by 2026 (achieved in 2022)

Environmental Challenges

  • Concentration of personnel and facilities at a single site, posing risk from natural disasters (flooding)
  • Risk of infectious diseases and cyberattacks
Mitigation Strategies
  • Emergency power supply installed, evacuation space designated, three days' worth of food and water stockpiled, regular disaster drills conducted
  • Information Security Manager appointed, measures to prevent information leakage implemented, external expert utilized for incident response

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Flooding
Opportunities
  • Increased need for research and development of infectious diseases

Reporting Standards

Frameworks Used: TCFD

Certifications: CASBEE S rating (headquarters and laboratories)

UN Sustainable Development Goals

  • SDG 3: Good Health and Well-being

Contribution through research activities

Awards & Recognition

  • TOP-RATED ESG PERFORMER 2022 from Sustainalytics

Reporting Period: 2023

Environmental Metrics

ESG Focus Areas

  • Climate change/CO2 emission reduction
  • Waste reduction
  • Biodiversity conservation
  • Addressing unmet medical needs through the discovery of transformational medicines
  • Responsible sourcing/Stable product supply
  • Community relations
  • Cultivating a culture of innovation/Ensuring diversity in core human resources
  • Respecting human rights/Occupational health and safety
  • Corporate governance
  • Compliance and risk management
  • Stakeholder engagement

Environmental Achievements

  • Achieved carbon neutrality across PeptiDream operations for 3 consecutive years
  • PDRadiopharma decided to switch to renewable energy
  • Set group-wide carbon emission reduction target for SBT accreditation

Social Achievements

  • Reformed HR system based on newly defined Values & Behaviors
  • Visualization of employee engagement
  • Continued efforts to enhance cybersecurity
  • Formulated basic policies and personnel requirements for CEO succession plan
  • BPC measures against large-scale natural disasters

Governance Achievements

  • Strengthened supervisory by independent Outside Directors and the Auditing Committee
  • Selected as an index constituent of the FTSE4Good Index Series and FTSE Blossom Japan Index
  • Achieved A- rating from CDP for the second consecutive year

Climate Goals & Targets

Medium-term Goals:
  • Reduce Scope 1+2 emissions by 100% by 2030 (vs 2023 baseline)
  • Reduce Scope 3 CO2 emissions by 20% by 2030 (vs 2023 baseline)

Environmental Challenges

  • Challenges to attract and retain top talent due to labor shortages in Japan
  • Intensifying conflicts between or within nations, political, economic and social decoupling and security crisis
Mitigation Strategies
  • Strengthening recruitment competitiveness and securing human resources through improving employee engagement; responding to societal changes such as rising wage levels and diversifying work styles
  • Diversifying the supply of raw materials to multiple regions and companies

Supply Chain Management

Supplier Audits: 100% response rate for major raw material suppliers

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Temporary suspension of business operation due to damage to facilities caused by natural disasters and restrictions on the supply of various infrastructures
Transition Risks
  • Increased costs due to the introduction of carbon taxes

Reporting Standards

Frameworks Used: GRI, TCFD

Reporting Period: FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)

Environmental Metrics

Total Carbon Emissions:0 tCO2e (Scope 1+2) in FY2022
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:100% of electricity from renewable sources in 2022
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Climate Change/CO2 Emission Reduction
  • Waste Reduction
  • Biodiversity Conservation
  • Responsible Sourcing/Stable Product Supply
  • Community Relations
  • Corporate Governance
  • Compliance and Risk Management
  • Cultivating a culture of innovation/Ensuring diversity in core human resources
  • Respecting human rights/Occupational health and safety
  • Addressing unmet medical needs through the discovery of transformational medicines
  • Stakeholder Engagement

Environmental Achievements

  • Achieved carbon neutrality across business operations (Scope 1+2) in 2022
  • Reduced electricity consumption per employee by approximately 12% year-on-year by optimization of power management

Social Achievements

  • Conducted first diversity and inclusion training
  • 100% of female employees and 75% of male employees took childcare leave; 100% return rate for both
  • Conducted first sustainability procurement survey to major suppliers and collected 100% of survey responses

Governance Achievements

  • Strengthened corporate governance to achieve higher standards than those required in Prime Market level
  • Established Compliance Risk Management Committee to strengthen risk management
  • Appointed outside Director as Chairperson of the Board

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Potential business interruption due to natural disasters (flooding) affecting facilities and infrastructure in Tonomachi, Kawasaki City.
  • Cybersecurity threats
Mitigation Strategies
  • Emergency power supply installed, R&D equipment on multiple floors, three days' worth of food and water stockpiled for employees.
  • 24/7 security monitoring, server-less systems, strict endpoint management, and regular cybersecurity awareness training for employees.

Supply Chain Management

Supplier Audits: 100% response rate to sustainability procurement survey in 2022

Responsible Procurement
  • Sustainability procurement survey based on GCNJ questionnaire; Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather, flooding (Tama River)
Transition Risks
  • Regulatory changes, market shifts
Opportunities
  • Increased demand for new drug co-development due to climate change-related health issues

Reporting Standards

Frameworks Used: TCFD

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • A- (A minus) rating from CDP’s 2022 Climate Change Report